Health history
Review relevant conditions, previous care, symptoms, and the complete health picture that may affect eligibility or treatment decisions.
GLP-1 weight loss · California
Medication is one part of the plan. Thoughtful medical guidance brings the rest together.
GLP-1 treatment begins with a medical conversation about you.
GLP-1 is a hormone involved in appetite and calorie intake. Prescription medications that act on GLP-1 receptors may support appetite regulation for some qualified patients. The exact medication, if any, depends on individual health information, medication-specific criteria, current availability, and clinical judgment.
MEDY reviews your health history, current medications, previous weight-loss efforts, preferences, and goals before discussing options. Treatment is not automatic, and no medication produces the same response for every patient.
When treatment is appropriate, follow-up creates space to discuss response, tolerance, questions, and whether the plan should change. Nutrition, movement, daily routines, and longer-term planning remain part of the conversation.
MEDY’s clinical care is led by Christel Backert, NP-C, with treatment decisions made one patient at a time rather than through a preset product package.
The decision is based on more than a number on the scale.
Review relevant conditions, previous care, symptoms, and the complete health picture that may affect eligibility or treatment decisions.
Discuss prescriptions, over-the-counter medications, supplements, possible interactions, and information your provider needs before recommending care.
Talk through what you have tried, what felt sustainable, what did not work for you, and where additional medical support may help.
Set realistic expectations for treatment, monitoring, daily routines, and the fact that response and tolerance differ from person to person.
A monitored process with room to adjust as your needs become clearer.
Review health history, medications, previous efforts, goals, and medication-specific eligibility considerations.
Discuss appropriate options, limitations, potential risks and benefits, alternatives, and what the plan would require.
Receive medication-specific guidance and a follow-up plan when treatment is prescribed.
Review response, tolerance, questions, and whether continuation or a change is clinically appropriate.
The medication category does not tell the whole safety story.
Possible side effects and serious risks vary by medication and by patient. Gastrointestinal effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort can occur with some GLP-1 medicines. Your provider reviews medication-specific labeling, contraindications, interactions, and warning signs with you.
FDA approval applies to specific products and specific uses—not to an entire category or every formulation. This page does not present all GLP-1 products as interchangeable or promise a particular medication before evaluation.
Do not start, stop, change, or share a prescription based on website information. Follow the directions provided with your medication and contact the prescribing clinician with treatment or side-effect questions.
No. Your provider determines whether prescription treatment may be appropriate after reviewing your individual health information, medication-specific criteria, and available options.
Available options can change with clinical, supply, and regulatory circumstances. MEDY discusses currently available and medically appropriate options during your individual evaluation rather than promising a fixed product inventory online.
No. Response, tolerance, pace of progress, and longer-term needs vary. MEDY does not promise a specific amount or timeline of weight loss.
No. Medication may be one part of care. Practical nutrition, movement, routines, monitoring, and maintenance planning remain individualized parts of the broader conversation.
Some California patients may qualify for telehealth based on MEDY’s distance and other eligibility requirements. MEDY confirms the patient’s physical location for the visit and whether care can be provided before the appointment proceeds.
Discuss changes with the prescribing provider first. Your provider can review your reason, current response, medication-specific considerations, and an appropriate next step.